Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 1
2007 1
2008 2
2009 1
2010 2
2012 2
2013 1
2019 1
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
Lee P, Loo BW Jr, Biswas T, Ding GX, El Naqa IM, Jackson A, Kong FM, LaCouture T, Miften M, Solberg T, Tome WA, Tai A, Yorke E, Li XA. Lee P, et al. Among authors: el naqa im. Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):160-171. doi: 10.1016/j.ijrobp.2019.03.045. Epub 2019 Apr 5. Int J Radiat Oncol Biol Phys. 2021. PMID: 30954520 Free PMC article. Review.
Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary.
Tarhini AA, Lee SJ, Tan AC, El Naqa IM, Stephen Hodi F, Butterfield LH, LaFramboise WA, Storkus WJ, Karunamurthy AD, Conejo-Garcia JR, Hwu P, Streicher H, Sondak VK, Kirkwood JM. Tarhini AA, et al. Among authors: el naqa im. J Immunother Cancer. 2022 Jan;10(1):e004310. doi: 10.1136/jitc-2021-004310. J Immunother Cancer. 2022. PMID: 35074904 Free PMC article. Clinical Trial.
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
Saad M, Lee SJ, Tan AC, El Naqa IM, Hodi FS, Butterfield LH, LaFramboise WA, Storkus W, Karunamurthy AD, Conejo-Garcia J, Hwu P, Streicher H, Sondak VK, Kirkwood JM, Tarhini AA. Saad M, et al. Among authors: el naqa im. J Transl Med. 2022 Jun 3;20(1):253. doi: 10.1186/s12967-022-03450-3. J Transl Med. 2022. PMID: 35659704 Free PMC article.
Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator.
Weygand J, Armstrong T, Bryant JM, Andreozzi JM, Oraiqat IM, Nichols S, Liveringhouse CL, Latifi K, Yamoah K, Costello JR, Frakes JM, Moros EG, El Naqa IM, Naghavi AO, Rosenberg SA, Redler G. Weygand J, et al. Among authors: el naqa im. Phys Imaging Radiat Oncol. 2023 Nov 8;28:100505. doi: 10.1016/j.phro.2023.100505. eCollection 2023 Oct. Phys Imaging Radiat Oncol. 2023. PMID: 38045642 Free PMC article.
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors.
Eljilany I, Saghand PG, Chen J, Ratan A, McCarter M, Carpten J, Colman H, Ikeguchi AP, Puzanov I, Arnold S, Churchman M, Hwu P, Conejo-Garcia J, Dalton WS, Weiner GJ, El Naqa IM, Tarhini AA. Eljilany I, et al. Among authors: el naqa im. Cancers (Basel). 2023 Oct 10;15(20):4913. doi: 10.3390/cancers15204913. Cancers (Basel). 2023. PMID: 37894280 Free PMC article.
18 results